Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
51%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
43%
ALSO IN MEDX
MEDX
28
HOLDINGS
36%
ALSO IN PPH
SECTOR DRIFT (PPH minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.7% | 13.9% | 13.9% |
 |
NOVARTIS AG-ADR | 7.9% | 7.1% | 7.1% |
|
JOHNSON & JOHNSON | 11.6% | 5.0% | 5.0% |
|
ABBVIE INC | 5.0% | 9.4% | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% | 5.4% | 5.0% |
PPH Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 6.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.1% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
MCKESSON CORP | 4.4% |
|
ZOETIS INC | 4.3% |
|
CENCORA INC | 3.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.9% |
|
MERCK & CO. INC. | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 1.8% |
PPH Underweight Relative to MEDX
|
ALNYLAM PHARMACEUTICALS INC | -6.6% |
|
ABBVIE INC | -4.4% |
|
AMGEN INC | -4.0% |
 |
ALKERMES PLC | -4.0% |
|
CRISPR THERAPEUTICS AG | -3.3% |
|
IONIS PHARMACEUTICALS, INC. | -3.1% |
|
BIOGEN IDEC INC | -2.5% |
|
REGENERON PHARMACEUTICALS | -2.5% |
|
GALECTIN THERAPEUTICS INC | -1.3% |
|
BEAM THERAPEUTICS, INC. | -0.9% |